aponvie
Generic: aprepitant
aponvie: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Approved |
FDA Decisions
Approval(HRTX)
Frequently asked questions
Who is developing aponvie?
aponvie is being developed by HERON THERAPEUTICS, INC. /DE/.
What is aponvie's latest FDA decision?
The most recent tracked FDA decision for aponvie is Approval, dated September 16, 2022.
Get deeper analysis on aponvie
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis